FemTech Market Summary

The FemTech market is rapidly redefining women’s healthcare through technology-driven innovation and personalized digital solutions. Valued at USD 39.29 billion in 2024, the global FemTech market is projected to climb to USD 97.25 billion by 2030, expanding at a robust CAGR of 16.37% from 2025 to 2030. This acceleration reflects the growing integration of digital health platforms, AI-enabled tools, and virtual assistants designed to deliver more customized, accessible, and efficient healthcare solutions for women.

A key growth catalyst is the rising adoption of digital health applications tailored specifically to women’s needs. Advanced technologies such as artificial intelligence are transforming traditional care models by enabling predictive insights, symptom tracking, and personalized wellness guidance. These innovations are helping bridge long-standing gaps in women’s healthcare by providing data-driven and patient-centric support.

Investment momentum is also playing a pivotal role in shaping the sector’s expansion. Venture capital firms and institutional investors are increasingly channeling funds into solutions focused on women’s well-being. Notably, investor attention has broadened beyond fertility and pregnancy to include menopause management, menstrual health, mental health, and other historically underserved areas.

Order a free sample PDF of the FemTech Market Intelligence Study, published by Grand View Research.

In November 2022, teletherapy platform Maven Clinic secured USD 90 million in Series E funding, led by General Catalyst with participation from Sequoia Capital, Intermountain Ventures, and CVS Health Ventures. With over USD 300 million raised in total, the company exemplifies growing investor confidence in the FemTech ecosystem. Such funding rounds are strengthening innovation pipelines and expanding access to specialized women’s healthcare services.

Increased R&D activity and heightened awareness around women’s health challenges are further fueling expansion. For example, in March 2022, entrepreneur Sasha Cayward introduced an AI-powered menstrual health app offering personalized recommendations on fitness, nutrition, and productivity alongside cycle tracking and symptom monitoring. Developments like these are broadening the scope of FemTech solutions and enhancing user engagement across life stages.

Key Market Trends & Insights

• North America led the FemTech market with a 45.90% revenue share in 2024.
• The U.S. accounted for the largest regional share in 2024.
• By type, the devices segment dominated with a 33.33% revenue share in 2024.
• By application, pregnancy and nursing care emerged as the leading segment in 2024.
• By end use, the direct-to-consumer segment held a 30.82% revenue share in 2024.

Market Size & Forecast

• 2024 Market Size: USD 39.29 Billion
• 2030 Projected Market Size: USD 97.25 Billion
• CAGR (2025–2030): 16.37%
• Largest Region in 2024: North America
• Fastest Growing Region: Asia Pacific

Key FemTech Company Insights

The FemTech ecosystem remains highly fragmented, with numerous country-level service providers and emerging startups contributing to innovation. Companies such as Ava, Bloomlife, Bonzun, and Kegg are actively developing specialized solutions addressing fertility tracking, prenatal care, and hormonal health management.

Leading FemTech Companies

The following organizations collectively hold significant shares and influence sector-wide trends:

• Chiaro Technology Limited
• HeraMED
• Flo Health, Inc.
• Natural Cycles USA Corp
• Glow, Inc
• Allara Health
• NUVO Inc.
• Bloomlife
• Syrona Health
• Sirona Hygiene Private Limited
• Samplytics Technologies Private Limited
• iSono Health, Inc.
• Athena Feminine Technologies

Explore Horizon Databook - The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The FemTech market is entering a transformative growth phase, driven by technological innovation, rising investment inflows, and increasing awareness of women’s health needs. With revenues projected to expand from USD 39.29 billion in 2024 to USD 97.25 billion by 2030, advancing at a 16.37% CAGR, the sector reflects both strong investor confidence and growing consumer adoption. North America continues to lead, while Asia Pacific demonstrates accelerating momentum. As digital tools, AI-powered applications, and direct-to-consumer platforms reshape healthcare delivery, FemTech is poised to play a central role in advancing personalized and accessible women’s health solutions worldwide.